Osteoporosis



Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis


Condition:   Osteoporosis
Intervention:   Drug: Zoledronic Acid
Sponsors:   Aarhus University Hospital;   University of Aarhus;   Amgen
Recruiting - verified March 2017


A Comparison of PF708 and Forteo in Osteoporosis Patients


Condition:   Osteoporosis
Interventions:   Drug: Teriparatide (PF708);   Drug: Teriparatide (Forteo)
Sponsor:   Pfenex, Inc
Recruiting - verified December 2016


Multicenter Cohort Study on Osteoporosis


Condition:   Osteoporosis
Intervention:  
Sponsors:   Shanghai University of Traditional Chinese Medicine;   Wangjing Hospital, China Academy of Chinese Medical Sciences;   Dongzhimen Hospital, Beijing;   The 309th Hospital of Chinese People's Libertation Army;   The First Affiliated Hospital, Guangzhou University of TCM;   Guangdong Provincial Hospital of Traditional Chinese Medicine;   Affliliated Hospital of Changchun University of Chinese Medicine;   Gansu Provincial Hospital;   Luoyang Zhenggu Hospital;   Guangzhou Kingmed Diagnostics Co., Ltd.
Not yet recruiting - verified November 2016


Qualitative Study on Osteoporosis Representation and Management in the General Population and in General Practitioners.


Condition:   Osteoporosis
Intervention:   Other: qualitative study
Sponsor:   Hospices Civils de Lyon
Active, not recruiting - verified July 2016


PTH and Vibration in OSteoporosis Study


Condition:   Osteoporosis
Interventions:   Other: whole-body vibration;   Drug: teriparatide
Sponsors:   Odense University Hospital;   University of Southern Denmark;   Copenhagen University Hospital, Denmark;   Hospital of South West Denmark;   Sygehus Lillebaelt;   OPEN - Odense Patient data Explorative Network;   Region of Southern Denmark
Recruiting - verified June 2016


Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France


Condition:   Post Menopausal Osteoporosis
Interventions:   Drug: AMG 162 - Prolia;   Drug: AMG 162 - Prolia
Sponsor:   Amgen
Active, not recruiting - verified April 2017


The Relationship Between the Residual Renal Function and Osteoporosis Treatment


Condition:   Osteoporosis
Intervention:   Drug: Bis, SERM Teriparatide, Denosumab
Sponsor:   Toshihiko Kono
Recruiting - verified November 2016


Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment


Condition:   Osteoporosis
Intervention:   Drug: Generic alendronate
Sponsor:   Mahidol University
Recruiting - verified September 2016


Screening for Osteoporosis in General Practice


Condition:   Osteoporosis
Intervention:  
Sponsors:   Aalborg University;   Aalborg Universitetshospital
Completed - verified July 2016


A Double-blind Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis


Condition:   Osteoporosis in Men
Interventions:   Drug: AMG 785;   Drug: Placebo
Sponsor:   Amgen
Completed - verified September 2016


The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab


Condition:   Osteoporosis
Interventions:   Drug: Standard Clinical Practice Regimen;   Drug: Experimental Cyclic Regimen
Sponsor:   Health Research, Inc.
Active, not recruiting - verified November 2016


Bindex Ultrasonometer for Osteoporosis Diagnostics


Condition:   Osteoporosis
Intervention:  
Sponsors:   Bone Index Finland Ltd;   HealthEast Care System
Terminated - verified May 2017


A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care


Condition:   Osteoporosis
Intervention:   Behavioral: Video-based Intervention
Sponsors:   University of Alabama at Birmingham;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);   University of Massachusetts, Worcester;   Helen Hayes Hospital;   Group Health Cooperative;   Cedars-Sinai Medical Center;   University of Pittsburgh;   University of Cincinnati
Completed - verified November 2016


Gaining Optimal Osteoporosis Assessments in Long-Term Care (GOAL)


Condition:   Osteoporosis
Intervention:   Other: Knowledge Translation Education Sessions
Sponsors:   Hamilton Health Sciences Corporation;   McMaster University
Completed - verified December 2016


Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis


Condition:   Postmenopausal Women With Osteoporosis
Interventions:   Drug: Romosozumab;   Drug: Alendronate
Sponsor:   Amgen
Active, not recruiting - verified March 2017


Arteos II Study: Relationship Between Osteoporosis and Arterial Rigidity Within Fractured Patients Cohort


Condition:   Osteoporosis
Intervention:  
Sponsor:   Central Hospital, Nancy, France
Recruiting - verified June 2016


Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis


Condition:   Postmenopausal Osteoporosis
Interventions:   Drug: Romosozumab;   Drug: Placebo;   Drug: Denosumab
Sponsor:   Amgen
Completed - verified April 2017


Multi-joint Coordination Underlies Upright Balance Control in Elderly With Osteoporosis


Condition:   Osteoporosis
Intervention:  
Sponsor:   National Taiwan University Hospital
Completed - verified December 2016


Osteoporosis Research Registry


Condition:   Osteoporosis
Intervention:  
Sponsors:   Northwestern University;   Rehabilitation Institute of Chicago
Completed - verified December 2016


Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis


Condition:   Osteoporosis
Intervention:   Drug: Teriparatide
Sponsor:   University Health Network, Toronto
Recruiting - verified October 2016


A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.


Condition:   Osteoporosis
Interventions:   Drug: Ronacaleret;   Drug: Teriparatide;   Drug: Alendronate
Sponsor:   GlaxoSmithKline
Terminated - verified November 2016


Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate


Condition:   Osteoporosis
Interventions:   Drug: Ibandronate;   Drug: Alendronate
Sponsor:   GlaxoSmithKline
Completed - verified January 2017


A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo


Condition:   Osteoporosis
Interventions:   Drug: ibandronate;   Drug: Placebo
Sponsor:   Hoffmann-La Roche
Completed - verified November 2016


Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis


Condition:   Osteoporosis
Intervention:   Drug: Zoledronic Acid
Sponsor:   Novartis Pharmaceuticals
Completed - verified May 2017


Treatment of Childhood Osteoporosis With Alendronate (Fosamax)


Condition:   Osteoporosis
Intervention:   Drug: Alendronate
Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed - verified September 2016

Refine Your Search Advanced Search